Drug Reference

meningococcal group B vaccine / Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine

Brand names

Penbraya

Available as

0.5 ML · Injection

Multi-ingredient product

Meningococcal Group B VaccineNeisseria Meningitidis Serogroup A Capsular Polysaccharide Tetanus Toxoid Protein Conjugate VaccineNeisseria Meningitidis Serogroup C Capsular Polysaccharide Tetanus Toxoid Protein Conjugate VaccineNeisseria Meningitidis Serogroup W-135 Capsular Polysaccharide Tetanus Toxoid Protein Conjugate VaccineNeisseria Meningitidis Serogroup Y Capsular Polysaccharide Tetanus Toxoid Protein Conjugate Vaccine

This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.

Current FDA labels (DailyMed)

PENBRAYA (MENINGOCOCCAL GROUPS A, B, C, W, AND Y VACCINE) KIT [PFIZER LABORATORIES DIV PFIZER INC]

2 marketed products on record (RxNorm)

Authoritative sources

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.